Kratom: a dangerous player in the opioid crisis

Area of Science:

• Toxicology
• Hepatology
• Pharmacology

Background:

• Kratom (Mitragyna speciosa) use is increasing, with limited data on its adverse effects.
• Regulatory bodies like the DEA and FDA have flagged kratom as a substance of concern due to abuse potential.
• The full spectrum of kratom's therapeutic and toxicological profile remains poorly understood.

Observation:

• A 32-year-old male presented with acute illness, jaundice, and elevated liver enzymes.
• The patient's condition exhibited a cholestatic liver injury pattern.
• The patient had a documented history of kratom consumption.

Findings:

• Kratom use was identified as the likely cause of the patient's cholestatic liver injury.
• The case demonstrates a potentially severe adverse outcome associated with kratom use.
• Successful treatment and recovery were achieved in this patient.

Implications:

• Increased awareness of kratom-induced hepatotoxicity is crucial for clinicians.
• Kratom's role in the expanding opioid crisis warrants further investigation.
• Balancing perceived therapeutic benefits against potentially lethal side effects of kratom is a critical public health consideration.